An open-label trial of 12-week simeprevir plus Peginterferon/Ribavirin (PR) in treatment-naïve patients with Hepatitis C Virus (HCV) Genotype 1 (GT1)

Antonio Craxi, Isabelle Lonjon-Domanec, Michael Gschwantler, Maria Buti, Michael Schlag, Jane Scott, Maria Buti, Gino Van Dooren, Robert Ryan, Oliver Lenz, Peter Buggisch, Christoph Sarrazin, Graham R. Foster, Tarik Asselah, Christophe Moreno

Risultato della ricerca: Articlepeer review

4 Citazioni (Scopus)

Fingerprint

Entra nei temi di ricerca di 'An open-label trial of 12-week simeprevir plus Peginterferon/Ribavirin (PR) in treatment-naïve patients with Hepatitis C Virus (HCV) Genotype 1 (GT1)'. Insieme formano una fingerprint unica.

Medicine & Life Sciences

Chemical Compounds

Agriculture & Biology